Literature DB >> 20825397

Incidence and survival of patients with carcinoma of the ureter and renal pelvis in the USA, 1973-2005.

Jay D Raman1, Jamie Messer, John A Sielatycki, Christopher S Hollenbeak.   

Abstract

OBJECTIVE: • To evaluate epidemiological and survival patterns of upper-tract urothelial carcinoma (UTUC) over the past 30 years through a review of a large, population-based database. PATIENTS AND METHODS: • Data from the Surveillance, Epidemiology and End Results (SEER) database from 1973 to 2005 were reviewed in 10-year increments to evaluate disease trends. • Univariate and multivariate survival analyses identified prognostic variables for outcomes.
RESULTS: •In total, 13,800 SEER-registered cases of UTUC were included. The overall incidence of UTUC increased from 1.88 to 2.06 cases per 100,000 person-years during the period studied, with an associated increase in ureteral disease (0.69 to 0.91) and a decrease in renal pelvic cancers (1.19 to 1.15). • The proportion of in situ tumours increased from 7.2% to 31.0% (P < 0.001), whereas local tumours declined from 50.4% to 23.6% (P < 0.001). • There was no change in the proportion of patients presenting with distant disease. • In multivariate analysis, increasing patient age (P < 0.001), male gender (P < 0.001), black non-Hispanic race (P < 0.001), bilateral UTUC (P = 0.001) and regional/distant disease (P < 0.001) were all associated with poorer survival outcomes.
CONCLUSIONS: • The incidence of UTUC has slowly risen over the past 30 years. • Increased use of bladder cancer surveillance regimens and improved abdominal cross-sectional imaging may contribute to the observed stage migration towards more in situ lesions. • Although pathological disease characteristics impact cancer outcomes, certain sociodemographic factors also appear to portend worse prognosis.
© 2010 THE AUTHORS. BJU INTERNATIONAL © 2010 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2010        PMID: 20825397     DOI: 10.1111/j.1464-410X.2010.09675.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  104 in total

Review 1.  [Upper tract urothelial carcinoma. An update on clinical and pathological prognostic factors].

Authors:  M Rink; M Adam; J Hansen; F K Chun; S A Ahyai; M Remzi; T Schlomm; O Engel; R Heuer; C Eichelberg; M Fisch; R Dahlem; S F Shariat
Journal:  Urologe A       Date:  2012-09       Impact factor: 0.639

Review 2.  Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need.

Authors:  Mounsif Azizi; Salim K Cheriyan; Charles C Peyton; Beat Foerster; Shahrokh F Shariat; Philippe E Spiess
Journal:  Curr Treat Options Oncol       Date:  2019-04-01

3.  Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract.

Authors:  Eiji Kashiwagi; Kazutoshi Fujita; Seiji Yamaguchi; Hiroaki Fushimi; Hiroki Ide; Satoshi Inoue; Taichi Mizushima; Leonardo O Reis; Rajni Sharma; George J Netto; Norio Nonomura; Hiroshi Miyamoto
Journal:  Cancer Biol Ther       Date:  2016-09-16       Impact factor: 4.742

4.  Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.

Authors:  Matthew R Danzig; Katherine Mallin; James M McKiernan; Walter M Stadler; Srikala S Sridhar; Todd M Morgan; Bernard H Bochner; Cheryl T Lee
Journal:  Cancer       Date:  2018-04-06       Impact factor: 6.860

Review 5.  Prognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.

Authors:  Aurélie Mbeutcha; Morgan Rouprêt; Ashish M Kamat; Pierre I Karakiewicz; Nathan Lawrentschuk; Giacomo Novara; Jay D Raman; Christian Seitz; Evanguelos Xylinas; Shahrokh F Shariat
Journal:  World J Urol       Date:  2016-04-21       Impact factor: 4.226

6.  Transitional cell carcinoma of the renal pelvis with venous tumor thrombus.

Authors:  Onkar Singh; Arun Jacob Phillip George; J Chandra Singh; Antony Devasia
Journal:  Rev Urol       Date:  2017

7.  High-grade invasive urothelial carcinoma of the ureter with systematic lymph node metastasis successfully treated by nephroureterectomy followed by chemotherapy.

Authors:  Zhu-Qing Liu; Xi Zhang; Qing Xu
Journal:  Int J Clin Exp Med       Date:  2015-02-15

8.  A Novel Technique to Improve the Processing of Minute Ureteroscopic Biopsies.

Authors:  Shay Golan; Glenn Gerber; David Margel; Lea Rath-Wolfson; Yaron Ehrlich; Rumelia Koren; David Lifshitz
Journal:  Pathol Oncol Res       Date:  2017-04-03       Impact factor: 3.201

9.  A Festschrift in Honor of Edward M. Messing, MD, FACS.

Authors:  Jean V Joseph; Ralph Brasacchio; Chunkit Fung; Jay Reeder; Kevin Bylund; Deepak Sahasrabudhe; Shu Yuan Yeh; Ahmed Ghazi; Patrick Fultz; Deborah Rubens; Guan Wu; Eric Singer; Edward Schwarz; Supriya Mohile; James Mohler; Dan Theodorescu; Yi Fen Lee; Paul Okunieff; David McConkey; Hani Rashid; Chawnshang Chang; Yves Fradet; Khurshid Guru; Janet Kukreja; Gerald Sufrin; Yair Lotan; Howard Bailey; Katia Noyes; Seymour Schwartz; Kathy Rideout; Gennady Bratslavsky; Steven C Campbell; Ithaar Derweesh; Per-Anders Abrahamsson; Mark Soloway; Leonard Gomella; Dragan Golijanin; Robert Svatek; Thomas Frye; Seth Lerner; Ganesh Palapattu; George Wilding; Michael Droller; Donald Trump
Journal:  Bladder Cancer       Date:  2018-10-03

10.  Influence of preoperative factors on the oncologic outcome for upper urinary tract urothelial carcinoma after radical nephroureterectomy.

Authors:  Sophie Hurel; Morgan Rouprêt; Thomas Seisen; Eva Comperat; Véronique Phé; Stéphane Droupy; François Audenet; Géraldine Pignot; Xavier Cathelineau; Laurent Guy; Olivier Cussenot; Adil Ouzzane; Gregory Bozzini; Laurent Nison; Alain Ruffion; Pierre Colin
Journal:  World J Urol       Date:  2014-05-09       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.